HomeTagsFrank Gleeson

Frank Gleeson

Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy

Satellos Receives FDA and International Clearance to Commence Pediatric Phase 2 Testing of SAT-3247 for Duchenne Muscular Dystrophy

Potential of SAT-3247 to Restore Muscle Regeneration in Duchenne Published in Nature

Satellos Announces New Data Further Demonstrating Safety, Tolerability, and Functional Impact of SAT-3247 in First-in-Human Trial of Adults with Duchenne Muscular Dystrophy

Satellos submits IND to FDA for Phase 2 SAT-3247 Clinical Trial in Duchenne Muscular Dystrophy

Satellos Reports SAT-3247 Q1 2025 Results, Highlights Recent Company Progress and Future Plans

Satellos Prepares to Launch Phase 2 Clinical Study of SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

Satellos SAT-3247 Stem Cell Approach May Restore Muscle Regeneration in Duchenne Muscular Dystrophy

Satellos Announces Completed Enrollment of Phase 1 Clinical Trial of SAT-3247 in Healthy Volunteers

Popular

Frequently Asked Questions About Elevidys Used for DMD

Can Ekinci - August 21, 2026

Must Read

RGX-202 Duchenne Gene Therapy Shows NSAA Improvement and Microdystrophin Expression — But Important Biomarker Data Missing

CRISPR GuideX Tool: hfCas12Max in CRISPR-Based Therapeutics

Care Guidelines

Breathing Exercises in Duchenne Muscular Dystrophy: Respiratory Therapy, Pulmonary Care & Lung Support

About us

Together, we will keep fighting for better treatments and access for everyone with Duchenne.

Powered by Hostinger

Latest Articles

NewBiologix and Synastra Partner to Advance DMD Gene Therapy Manufacturing

Press Releases September 2, 2026 0

A new international collaboration is bringing together biotechnology expertise...

What Is Exon Deletion? Understanding Exon Deletions in Duchenne Muscular Dystrophy

DMD September 2, 2026 0

What is exon deletion, and why does it matter...

tRNA Research for Nonsense Mutations Offers New Hope for Genetic Disorders

Research August 30, 2026 0

Researchers at the University of Toronto, University Health Network...

Most Popular

Frequently Asked Questions About Elevidys Used for DMD

Approved Therapies August 21, 2026 0

Duchenne muscular dystrophy (DMD) is a genetic condition that...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Editorials April 10, 2026 0

The landscape of potential new gene therapies for Duchenne...

The Brutal Truth: Why Duchenne Muscular Dystrophy Treatment Costs Are Out of Control

Editorials April 6, 2026 0

The duchenne muscular dystrophy treatment cost has become one...

© 2024 - 2026 DMD Warrior. All rights reserved.